Ann Arbor, MI, United States of America
Lycera Corporation
Patents = 36
Forward Citations = 220
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
51 inventors (with patents filed for the assignee):
Lycera Corporation is a biopharmaceutical company focused on developing innovative oral immune modulators for the treatment of autoimmune diseases and cancer. The company's proprietary platform enables the discovery of small molecules that target immune cells to restore and maintain normal immune function. Lycera's goal is to create safe and effective therapies that provide substantial benefits to patients in need.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com